- Home
- NMTC vs RDI Comparison
NMTC vs RDI Comparison
Compare NMTC & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- RDI
- Stock Information
- Founded
- NMTC 2009
- RDI 1937
- Country
- NMTC United States
- RDI United States
- Employees
- NMTC N/A
- RDI N/A
- Industry
- NMTC Medical/Dental Instruments
- RDI Movies/Entertainment
- Sector
- NMTC Health Care
- RDI Consumer Discretionary
- Exchange
- NMTC Nasdaq
- RDI Nasdaq
- Market Cap
- NMTC 33.8M
- RDI 27.9M
- IPO Year
- NMTC N/A
- RDI N/A
- Fundamental
- Price
- NMTC $0.83
- RDI $1.33
- Analyst Decision
- NMTC Strong Buy
- RDI
- Analyst Count
- NMTC 1
- RDI 0
- Target Price
- NMTC $1.45
- RDI N/A
- AVG Volume (30 Days)
- NMTC 221.0K
- RDI 27.7K
- Earning Date
- NMTC 08-13-2025
- RDI 08-13-2025
- Dividend Yield
- NMTC N/A
- RDI N/A
- EPS Growth
- NMTC N/A
- RDI N/A
- EPS
- NMTC N/A
- RDI N/A
- Revenue
- NMTC $5,758,777.00
- RDI $205,644,000.00
- Revenue This Year
- NMTC $157.28
- RDI $7.47
- Revenue Next Year
- NMTC $41.79
- RDI $13.22
- P/E Ratio
- NMTC N/A
- RDI N/A
- Revenue Growth
- NMTC 54.53
- RDI N/A
- 52 Week Low
- NMTC $0.40
- RDI $1.17
- 52 Week High
- NMTC $1.39
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- NMTC 55.86
- RDI 46.02
- Support Level
- NMTC $0.81
- RDI $1.32
- Resistance Level
- NMTC $1.05
- RDI $1.45
- Average True Range (ATR)
- NMTC 0.08
- RDI 0.06
- MACD
- NMTC -0.00
- RDI 0.00
- Stochastic Oscillator
- NMTC 40.28
- RDI 16.67
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.